Jorge Conde
17 statements across 8 episodes · 12 bullish · 1 bearish · 1 people on the record · first statement Dec 15, 2017 by Jorge Conde · said 1 times in 1 episodes since 2018 · across every show →
On the record as a speaker too: Jorge Conde's record, appearances and statements → this page counts the times other people say the name.
Mentions by year
brought up most by Benedict Evans (1)
tap a year for its mentions
2018 1 mention in 1 episode
Everything said about Jorge Conde, oldest first
Dec 15, 2017 bullish
Mar 23, 2018 positive
Conde: Engineering principles make subsequent drug candidates more valuable than earlier ones
“But in your world, in the world you're describing, this engineering world, it's actually the reverse is true. That the second drug is more valuable than the first if you're using engineering principles, because what you learn from example one sort of imbues va…”
Apr 30, 2018 positive
Conde: Skilled business development teams bridge a fatal chasm for bio startups
“Business development in the bio space is a fundamentally strategic advantage to have. If you have a team that is good at structuring business development deals, in other words, that has experience in the space, that allows you to actually help bridge what is o…”
Apr 30, 2018
Conde: Bio entrepreneurs must prioritize and execute early killer experiments
“If you're developing technology in the biology space, you should know what your near term killer experiment is. And the experiment that if it does not work, It's, you know, kill mode for whatever you're developing. And you should know what that is. You should …”
Apr 30, 2018 negative
Conde: Bio startup pilot projects often take twice as long as expected
“If you were, you thought you would finish pilot, you know, a pilot project and get paid X in Y amount of time, oftentimes you're getting paid X in something like two X, two times the Y amount of time, and you're also working a lot harder if there's been scope …”
Apr 30, 2018
Conde: Bio platforms should target high-end research institutions before expanding down-market
“And you sell to the high end of the market first, right? So what, you know, what we saw with happening with sequencing was that obviously in the very early days when, you know, the throughput of the sequencer It was low, where the cost was very high. The only …”
Apr 30, 2018
Conde: Successful drug assets routinely starve underlying biotech platforms of resources
“All of the conversations start to focus on, well, we could always use more resources on making sure that the drug program succeeds, and there's only a fixed pool of resources, generally speaking, and so what ends up happening is the platform Get Start, and I t…”
Dec 22, 2018 positive
Synthetic biology enables cells and genes to become medicines themselves
“But with advances in synthetic biology, advances in our ability to use things like gene and cell engineering, we're increasingly finding ways to make those same cells and genes and microbes, not the target of medicines, but the medicines themselves.”
Dec 22, 2018
Living therapeutics require sensing, execution, containment, and termination
“So there are four fundamental things that these living things need to be able to do well to act as therapeutics. The first one is they need to be able to sense their environment. They need to be able to look and search for the presence of disease. The second t…”
Jan 2, 2019 bullish
Jan 2, 2019 positive
Jan 2, 2019 bullish
Conde: Biology will expand beyond healthcare to touch every major industry
“Biology is no longer an industry in and of itself. It's something that's going to touch every single industry, and we're already seeing applications in energy, in textiles, in food, of course in health, and in data storage.”
Jan 2, 2019 positive
Conde: Human genome sequencing cost dropped from $3B to under $1,000
“Today, because of improvements that were born of the application of engineered disciplines and three very specific ones, we can now sequence a human genome in what used to take 13 years in a matter of hours, and what used to cost three billion dollars for less…”
Jan 2, 2019 bullish
Feb 26, 2019 positive
Conde: Canine oncology exhibits canonical data network effects
“What you're describing here is sort of a canonical data network effect that the more dogs you treat in more combinations results in better information to treat more dogs with better combinations and so on and so forth. So the product gets in continuously bette…”
Apr 29, 2020 positive
Healthcare technology will create new medical specialties like radiology did
“And I think one of the most surprising things we'll see is the emergence of new specialties that come from the use of technology in healthcare, much like radiologists, of course, came on the backs of the ability of the availability of x-ray technologies.”
Apr 29, 2020 bullish
Hospitals will specialize only in complex surgeries as care moves home
“And that's not to say that hospitals will disappear altogether, but I think what's very surprising is the kinds of procedures and activities that we'll see in hospitals will be specialized to the things that are so incredibly complex, like surgeries that requi…”